Based on this, we hypothesized that serum levels of GRP and IL-1β might be associated with CAC risk in patients with suspected CAD, offering potential insights into early detection and therapeutic strategies targeting CAC in this specific population. The gene discussed is GRP; the disease is coronary artery disorder.